Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
CA 2471777 A1 · Owner: Roussigne, Myriam · Inventors: Clouaire, Thomas; Girard, Jean-Philippe; Roussigne, Myriam
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to genes and proteins of the THAP (THanatos (death)- Associated Protein) family comprising a THAP domain and their use in , diagnostics, treatment of disease and in the identification of molecules for the treatment of disease. The invention also relates to the Par4 protein and SLC chemokine pathways, including the interaction of Par4 and SLC with THAP family proteins, and the recruitment and localization of Par4 to PML nuclear bodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 10, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 10, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 10, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.